By
Jaclyn Jaeger2021-09-07T19:08:00
The U.S. Food and Drug Administration’s “intended use” final rule reaffirms the agency’s wide latitude of discretion in establishing an off-label use case against pharmaceutical and medical device companies.
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
2025-01-15T19:05:00Z By Oscar Gonzalez
The U.S. Food and Drug Administration announced Wednesday it has revoked authorization for color additive Red No. 3 from food, beverages, and drugs. Health concerns over dye have existed since it was banned from cosmetics in 1990 after it was found that large doses led to the development of cancer ...
2026-02-06T15:34:00Z By Tom Fox
When a company rapidly adopts AI, compliance officers can be blindsided, tasked with governance almost immediately. Luckily, there is a guide from the U.S. Department of Justice to help.
2026-02-05T23:22:00Z By Oscar Gonzalez
At Compliance Week’s recent Artificial Intelligence and Compliance event, one message came through clearly: Companies are moving quickly to adopt AI, while compliance programs are still trying to catch up.
2026-01-28T18:21:00Z By Jaclyn Jaeger
The Securities and Exchange Commission has closed its Foreign Corrupt Practices Act investigation into Calavo Growers, three months after the Department of Justice closed its FCPA investigation into the produce and agriculture company.
2026-01-24T01:20:00Z By Ruth Prickett
The number of U.K. employment tribunal cases could rise following reforms in the Employment Rights Act 2025. Several changes take effect this year, including shorter unfair dismissal qualifying periods, day-one worker rights, stronger protections for pregnant women, and an end to exploitative contracts.
2026-01-21T20:51:00Z By Ruth Prickett
Long-awaited reforms to the U.K. audit regime have been “scrapped” from the government’s legislative plans. The decision has led to an outburst of disappointment and frustration from audit bodies and pension funds that argued the reforms would increase trust in companies and support growth.
Site powered by Webvision Cloud